USANA Health Sciences (NYSE:USNA) Sets New 52-Week Low at $43.83

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) shares reached a new 52-week low on Friday . The stock traded as low as $43.83 and last traded at $44.03, with a volume of 30518 shares changing hands. The stock had previously closed at $45.30.

Analyst Ratings Changes

Several research firms recently weighed in on USNA. StockNews.com upgraded shares of USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a research report on Friday, January 12th. DA Davidson reduced their price target on shares of USANA Health Sciences from $53.00 to $48.00 and set a "neutral" rating for the company in a research report on Thursday, February 22nd.

USANA Health Sciences Stock Down 3.0 %

The stock has a market cap of $845.26 million, a P/E ratio of 13.31, a price-to-earnings-growth ratio of 1.39 and a beta of 0.91. The business's 50-day simple moving average is $48.24 and its two-hundred day simple moving average is $49.80.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its earnings results on Tuesday, February 6th. The company reported $0.87 earnings per share for the quarter, topping analysts' consensus estimates of $0.52 by $0.35. The firm had revenue of $221.08 million during the quarter, compared to analyst estimates of $206.70 million. USANA Health Sciences had a net margin of 6.93% and a return on equity of 13.49%. Analysts anticipate that USANA Health Sciences, Inc. will post 2.73 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other USANA Health Sciences news, insider Robert A. Sinnott sold 3,945 shares of the stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $46.55, for a total transaction of $183,639.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, insider David Mulham Mulham sold 4,311 shares of the firm's stock in a transaction that occurred on Thursday, February 29th. The shares were sold at an average price of $47.76, for a total value of $205,893.36. Following the completion of the transaction, the insider now directly owns 7,825 shares in the company, valued at $373,722. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Robert A. Sinnott sold 3,945 shares of the firm's stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $46.55, for a total transaction of $183,639.75. The disclosure for this sale can be found here. Insiders sold 24,807 shares of company stock worth $1,200,791 over the last quarter. 0.33% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On USANA Health Sciences

Large investors have recently modified their holdings of the company. Lazard Asset Management LLC purchased a new stake in USANA Health Sciences in the second quarter valued at approximately $47,000. Quest Partners LLC purchased a new stake in USANA Health Sciences in the fourth quarter valued at approximately $66,000. FMR LLC raised its stake in USANA Health Sciences by 71.6% in the first quarter. FMR LLC now owns 1,057 shares of the company's stock valued at $66,000 after purchasing an additional 441 shares in the last quarter. CWM LLC raised its stake in USANA Health Sciences by 49.6% in the fourth quarter. CWM LLC now owns 1,267 shares of the company's stock valued at $68,000 after purchasing an additional 420 shares in the last quarter. Finally, Point72 Hong Kong Ltd purchased a new stake in USANA Health Sciences in the second quarter valued at approximately $69,000. 54.25% of the stock is currently owned by institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.